These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 29096097)

  • 21. Synthesis and anti-proliferative activity of some new quinoline based 4,5-dihydropyrazoles and their thiazole hybrids as EGFR inhibitors.
    George RF; Samir EM; Abdelhamed MN; Abdel-Aziz HA; Abbas SE
    Bioorg Chem; 2019 Mar; 83():186-197. PubMed ID: 30380447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EGFR, HER2 target based molecular docking analysis, in vitro screening of 2, 4, 5-trisubstituted imidazole derivatives as potential anti-oxidant and cytotoxic agents.
    Guda R; Kumar G; Korra R; Balaji S; Dayakar G; Palabindela R; Myadaraveni P; Yellu NR; Kasula M
    J Photochem Photobiol B; 2017 Nov; 176():69-80. PubMed ID: 28964888
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Discovery andw biological evaluation of novel 6,7-disubstituted-4-(2-fluorophenoxy)quinoline derivatives possessing 1,2,3-triazole-4-carboxamide moiety as c-Met kinase inhibitors.
    Zhou S; Liao H; Liu M; Feng G; Fu B; Li R; Cheng M; Zhao Y; Gong P
    Bioorg Med Chem; 2014 Nov; 22(22):6438-52. PubMed ID: 25438768
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design, synthesis, and molecular modeling of quinoline-based derivatives as anti-breast cancer agents targeting EGFR/AKT signaling pathway.
    Batran RZ; El-Daly SM; El-Kashak WA; Ahmed EY
    Chem Biol Drug Des; 2022 Mar; 99(3):470-482. PubMed ID: 34939319
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Novel diphenylthiazole derivatives with multi-target mechanism: Synthesis, docking study, anticancer and anti-inflammatory activities.
    Abdelazeem AH; El-Saadi MT; Said EG; Youssif BGM; Omar HA; El-Moghazy SM
    Bioorg Chem; 2017 Dec; 75():127-138. PubMed ID: 28938224
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Design, synthesis, and docking studies of phenylpicolinamide derivatives bearing 1H-pyrrolo[2,3-b]pyridine moiety as c-Met inhibitors.
    Zhu W; Wang W; Xu S; Tang Q; Luo R; Wang M; Gong P; Zheng P
    Bioorg Med Chem; 2016 Feb; 24(4):812-9. PubMed ID: 26810712
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Design, synthesis, and docking studies of afatinib analogs bearing cinnamamide moiety as potent EGFR inhibitors.
    Tu Y; OuYang Y; Xu S; Zhu Y; Li G; Sun C; Zheng P; Zhu W
    Bioorg Med Chem; 2016 Apr; 24(7):1495-503. PubMed ID: 26906472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Design, synthesis and anticancer evaluation of novel spirobenzo[h]chromene and spirochromane derivatives with dual EGFR and B-RAF inhibitory activities.
    Abdelatef SA; El-Saadi MT; Amin NH; Abdelazeem AH; Omar HA; Abdellatif KRA
    Eur J Med Chem; 2018 Apr; 150():567-578. PubMed ID: 29549841
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Design, synthesis and evaluation of azaacridine derivatives as dual-target EGFR and Src kinase inhibitors for antitumor treatment.
    Cui Z; Chen S; Wang Y; Gao C; Chen Y; Tan C; Jiang Y
    Eur J Med Chem; 2017 Aug; 136():372-381. PubMed ID: 28525838
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel morpholin-3-one fused quinazoline derivatives as EGFR tyrosine kinase inhibitors.
    Qin X; Lv Y; Liu P; Li Z; Hu L; Zeng C; Yang L
    Bioorg Med Chem Lett; 2016 Mar; 26(6):1571-1575. PubMed ID: 26879314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of a novel 6,7-disubstituted-4-(2-fluorophenoxy)quinolines bearing 1,2,3-triazole-4-carboxamide moiety as potent c-Met kinase inhibitors.
    Liu M; Hou Y; Yin W; Zhou S; Qian P; Guo Z; Xu L; Zhao Y
    Eur J Med Chem; 2016 Aug; 119():96-108. PubMed ID: 27155466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and synthesis of novel pyrazolo[3,4-d]pyrimidin-4-one bearing quinoline scaffold as potent dual PDE5 inhibitors and apoptotic inducers for cancer therapy.
    Ibrahim TS; Hawwas MM; Taher ES; Alhakamy NA; Alfaleh MA; Elagawany M; Elgendy B; Zayed GM; Mohamed MFA; Abdel-Samii ZK; Elshaier YAMM
    Bioorg Chem; 2020 Dec; 105():104352. PubMed ID: 33080494
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and antitumor activities of some new N1-(flavon-6-yl)amidrazone derivatives.
    Habashneh AY; El-Abadelah MM; Zihlif MA; Imraish A; Taha MO
    Arch Pharm (Weinheim); 2014 Jun; 347(6):415-22. PubMed ID: 24615985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis and biological evaluation of 2,3-dihydro-[1,4]dioxino[2,3-f]quinazoline derivatives as EGFR inhibitors.
    Qin X; Yang L; Liu P; Yang L; Chen L; Hu L; Jiang M
    Bioorg Chem; 2021 May; 110():104743. PubMed ID: 33714020
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigating molecular dynamics-guided lead optimization of EGFR inhibitors.
    Lavecchia MJ; Puig de la Bellacasa R; Borrell JI; Cavasotto CN
    Bioorg Med Chem; 2016 Feb; 24(4):768-78. PubMed ID: 26810832
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design, synthesis, molecular docking and cytotoxic evaluation of novel 2-furybenzimidazoles as VEGFR-2 inhibitors.
    Abdullaziz MA; Abdel-Mohsen HT; El Kerdawy AM; Ragab FAF; Ali MM; Abu-Bakr SM; Girgis AS; El Diwani HI
    Eur J Med Chem; 2017 Aug; 136():315-329. PubMed ID: 28505536
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, synthesis, and cytotoxic evaluation of novel furo[2,3-b]quinoline derivatives.
    Wang B; Li Q; Shi W; Chen L; Sun J
    Chem Biol Drug Des; 2018 Apr; 91(4):957-961. PubMed ID: 29197162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of 2-aryl-8-hydroxy (or methoxy)-isoquinolin-1(2H)-ones as novel EGFR inhibitor by scaffold hopping.
    Kang BR; Shan AL; Li YP; Xu J; Lu SM; Zhang SQ
    Bioorg Med Chem; 2013 Nov; 21(22):6956-64. PubMed ID: 24094432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, molecular docking and antitumor activity of novel pyrrolizines with potential as EGFR-TK inhibitors.
    Belal A
    Bioorg Chem; 2015 Apr; 59():124-9. PubMed ID: 25748126
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Design, synthesis, and biological evaluation of novel quinoline derivatives as small molecule mutant EGFR inhibitors targeting resistance in NSCLC: In vitro screening and ADME predictions.
    Kardile RA; Sarkate AP; Lokwani DK; Tiwari SV; Azad R; Thopate SR
    Eur J Med Chem; 2023 Jan; 245(Pt 1):114889. PubMed ID: 36375337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.